2022 Nelson’s Pediatric Antimicrobial Therapy, 28th Edition (Original PDF from Publisher)

Original price was: $36.95.Current price is: $6.00.

Format: Publisher PDF

Posted By: Dr_magic

0 Rating

published date: 11 Mar 22

By John S. Bradley MD, John D. Nelson MD, Dr. Barnett Elizabeth MD, Joseph B. Cantey MD MD MPH, David W. Kimberlin MD FAAP, Dr. Paul E Palumbo MD, Dr. Jason Sauberan PharmD, J. Howard Smart MD, Dr. William J Steinbach
Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.

TOPICS INCLUDE

  • Antimicrobial Therapy by Clinical Syndromes
  • Antimicrobial Therapy for Neonates
  • Choosing Among
    • Antibiotics
    • Antifungal Agents
    • Antiviral Agents
    • Antiparasitic Agents
  • Oral Step-down Therapy for Serious Infections
  • Prevention of Symptomatic Infection
  • Approach to Antibiotic Allergies
  • Antibiotic Stewardship

New in the 28th Edition

  • Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
  • Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022
  • Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptible
  • Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
  • New dosing for posaconazole suspension formulation
  • New approaches to mucormycosis
  • Added baloxavir for children 12+ years old
  • Online updates of COVID-19 therapies once emergency use authorization in children at http://www.aap.org/nelsons
  • Updated Nelson’s app also available

Product Details

  • Publisher ‏ : ‎ American Academy of Pediatrics; Twenty-eighth edition (April 15, 2022)
  • Language ‏ : ‎ English
  • Paperback ‏ : ‎ 366 pages
  • ISBN-10 ‏ : ‎ 1610025644
  • ISBN-13 ‏ : ‎ 978-1610025645
  • ISBN-13 ‏ : ‎ 9781610025645
  • eText ISBN: 9781610025652
  • Reading age ‏ : ‎ Baby and up

DETAILS

Rating

5 Stars
(0 Reviews)
4 Stars
(0 Reviews)
3 Stars
(0 Reviews)
2 Stars
(0 Reviews)
1 Stars
(0 Reviews)

Review This Book

Share Your Thoughts With Other Customers

Write a Customer Review